Document Classification

Section Type: METHODS

Text: During a prospective randomized trial, 250 Hp positive patients with either duodenal ulcer, erosive bulbitis, or gastritis and dyspepsia were treated using 14 days of therapy 1) pantoprazole 40 mg daily and clarithromycin 500 mg b. i. d. (PC), 2) pantoprazole 40 mg daily and clarithromycin 500 mg b. i. d. plus amoxicillin 1 g b. i. d. (PCA), or 3) bismuth subcitrate 120 mg t. i. d., roxithromycin 150 mg b. i. d., metronidazole 250 mg b. i. d. plus ranitidin 300 mg (BRMR).